Vaccines Related News
All vulnerable adults in the UK now vaccinated against COVID-19
More than 15.3 million vulnerable people in the UK – more than a quarter of all adults – have now been inoculated with their...
UK support will help with COVID-19 vaccinations in Pakistan
The UK’s support of the COVAX facility will help Pakistan with its COVID-19 vaccination programme.
The UK has contributed £548m to the global vaccine COVAX...
Government must be clear on vaccine information for BAME community
The government must be clear on information about vaccine creation to help vaccine uptake in the BAME community.
Since the start of the COVID-19 pandemic...
UK to undertake world-first COVID-19 alternating vaccine dose study
The UK is undertaking the world’s first clinical trial that aims to determine the safety and effects of using different vaccines for the first...
Oxford vaccine data suggests it reduces COVID-19 transmission
New data on the Oxford/AstraZeneca vaccine has suggested that it may have a substantial impact on transmission of COVID-19.
Analyses of PCR positive swabs from...
Novavax COVID-19 vaccine shows efficacy against Kent variant
Novavax has released data from its phase III COVID-19 vaccine candidate study that demonstrates it as effective against the Kent variant of the virus.
Conducted...
Valneva COVID-19 vaccine production begins in Scotland
Vaccine company Valneva has begun manufacturing of its COVID-19 vaccine candidate in Livingston, West Lothian, Scotland.
The UK government made a joint multi-million pound investment...
COVAX to deliver two billion COVID-19 vaccine doses by end of 2021
COVAX has announced the aligning of an advanced purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine, meaning it is now...
Third of pregnant women not vaccinated against whooping cough
New research has shown that despite whooping cough being highly contagious and serious for new-born babies, up to one third of women in the...
UK vaccinates four million people against COVID-19
More than four million people have received their first dose of the COVID-19 vaccines, with more than half of those over 80 receiving a...
A united approach to fighting COVID-19 in Europe
The European Commission has set out several actions to be taken across Europe to establish a united front in beating the COVID-19 virus.
The European...
Fast-tracking the use of copper in the NHS to tackle AMR
Rory Donnelly, clinical research director of Copper Clothing, discusses the need to fast track copper for use in the NHS as an antimicrobial material...
WHO emergency committee advises on new COVID-19 variants
The WHO Emergency Committee on COVID-19 met to review and advise on the new variants of COVID-19.
The committee met at the request of WHO...
First global resolution on meningitis prevention and control
A global roadmap to defeat meningitis by 2030 has been established under the leadership of the World Health Organization.
At the 73rd Session of the...
Global Ebola vaccine stockpile now established
A global stockpile of Ebola vaccines has now been established by four of the leading health and humanitarian organisations.
Led by the International Coordinating Group...
Moderna COVID-19 vaccine receives approval in UK
The British Government has now authorised the Moderna COVID-19 vaccine for use.
The Moderna COVID-19 vaccine has become the third in Britain to gain authorisation...
Pfizer-BioNTech vaccine shows protection against new COVID-19 strains
Results from a new study have shown that the Pfizer/BioNTech vaccine shows protection against two new mutant strains of coronavirus.
In an in vitro study...
COVID-19 immunity could last eight months, says research
New research has suggested that immunity to COVID-19 could last for up to eight months following infection.
The findings, which were based on blood samples...
World first COVID-19 smart vaccine patch
In a world first development, researchers are creating a COVID-19 smart vaccine patch that will deliver the vaccine as well as measure its efficacy.
The...
Second COVID-19 vaccine authorised by the European Commission
The European Commission has granted conditional marketing authorisation (CMA) for the Moderna COVID-19 vaccine – the second one to be authorised in the EU.
The...